Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06372925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06372925 · ClinicalTrials.gov record · last posted 2026-07-28

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Study acronym: V-ACCELERATE
StatusActive, Not Recruiting
PhasePhase 4
Started2024-07-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study is to evaluate the effect of Inclisiran on coronary atherosclerosis using intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in patients with acute myocardial infarction and elevated low-density lipoprotein cholesterol (LDL-C).

Protocol amendment history 4 changes detected by DataLookout

2026-07-29
Enrollment closed, study ongoing
2026-04-15
Trial status changed: Active, Not Recruiting → Recruiting
2026-04-15
Primary completion pushed: 2026-06-24 → 2026-12-30
2026-04-15
Completion pushed: 2026-06-24 → 2027-01-26
Trial Details
NCT Number NCT06372925
Lead Sponsor Novartis Pharmaceuticals
Conditions Plaque, Atherosclerotic
Enrollment 318 participants
Start Date 2024-07-09
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-28